P/E ratio for Invitae (NVTA)
P/E ratio as of May 2024 (TTM): -0.0060
According to Invitae 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.00603715. At the end of 2022 the company had a P/E ratio of -0.1393.
P/E ratio history for Invitae from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.1393 | -98.44% |
| 2021 | -8.93 | -6.02% |
| 2020 | -9.50 | 54.35% |
| 2019 | -6.16 | 10.22% |
| 2018 | -5.59 | 63.02% |
| 2017 | -3.43 | 30.76% |
| 2016 | -2.62 | 5.97% |
| 2015 | -2.47 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | -15.6 | 258,162.59% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | -0.0169 | 180.75% | 🇺🇸 USA |
 CareDx CDNA | -4.97 | 82,295.83% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.